166 results
8-K
EX-10.1
KA
Kineta Inc
24 Apr 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-10.2
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
8-K
EX-10.1
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
8-K
EX-10.1
KA
Kineta Inc
15 Dec 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
KA
Kineta Inc
17 Oct 23
Entry into a Material Definitive Agreement
8:32am
8-K
EX-10.1
huuiqqjfho25 kz8kvg
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.1
qqhe73sjsqsc
21 Jul 23
Entry into a Material Definitive Agreement
5:00pm
8-K/A
EX-10.1
zh3l2d 1ccw
2 Jun 23
Financial Statements and Exhibits
4:00pm
8-K
EX-10.2
81er4c1eqh0
30 May 23
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
935vn8xtg5i1764fva
30 May 23
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10
cugt8rzwqz
2 May 23
Entry into a Material Definitive Agreement
4:04pm
8-K
EX-10.1
d2u4r
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
8-K
EX-10.16
a4ki4qm
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.15
r6qq1474bihp
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.6
npa83w9i2nxzu1is4
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.17
4368nvda3jj
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.2
fwvcpmji2c
5 Dec 22
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
9:27am
8-K
EX-10.4
ihpw5s8009owm03s 8pu
5 Dec 22
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
9:27am